TriSalus Life Sciences Inc. (NASDAQ: TLSI)
$4.1200
-0.4100 ( -11.40% ) 51.4K
TriSalus Life Sciences Inc is an oncology company integrating standard-of-care treatments and its investigational immunotherapeutic, SD-101, with disruptive Pressure Enabled Drug Delivery infusion systems to transform the treatment paradigm for patients battling liver and pancreatic tumors. TriSalus is a commercial-stage medical device and Phase I clinical-stage pharmaceutical company.
Market Data
Open
$4.1200
Previous close
$4.5300
Volume
51.4K
Market cap
$127.16M
Day range
$4.1110 - $4.6690
52 week range
$3.6100 - $10.4200
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | May 07, 2024 |
| 3 | Insider transactions | 2 | May 07, 2024 |
| 8-k | 8K-related | 15 | Apr 30, 2024 |
| 8-k | 8K-related | 15 | Apr 16, 2024 |
| 10-k | Annual reports | 110 | Apr 11, 2024 |
| nt | Quarterly Reports | 1 | Apr 02, 2024 |
| 8-k | 8K-related | 15 | Apr 01, 2024 |
| 8-k | 8K-related | 15 | Mar 12, 2024 |
| 4 | Insider transactions | 1 | Feb 14, 2024 |
| 4 | Insider transactions | 1 | Feb 14, 2024 |